Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Zuqiang Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0986-7180; OpenAlex author ID A5101577027. Sources: OpenAlex.

Their work

Papers
10
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2013: 2 papers · 2014: 1 paper · 2015: 2 papers · 2016: 2 papers · 2017: 3 papers

Papers 10

  1. CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtype. Co-author DOI 10.1016/j.canlet.2016.10.046↗
  2. Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer. Co-author DOI 10.1245/s10434-016-5579-3↗
  3. Patients with normal-range CA19-9 levels represent a distinct subgroup of pancreatic cancer patients. Co-author DOI 10.3892/ol.2016.5501↗
  4. Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping. Co-author DOI 10.1016/j.pan.2016.09.013↗
  5. The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer. Co-author DOI 10.3390/ijms17071090↗
  6. Lymph node status predicts the benefit of adjuvant chemoradiotherapy for patients with resected pancreatic cancer. Co-author DOI 10.1016/j.pan.2015.03.012↗
  7. Blood neutrophil-lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapy. Co-author DOI 10.1245/s10434-014-4021-y↗
  8. Molecular mechanism underlying lymphatic metastasis in pancreatic cancer. Co-author DOI 10.1155/2014/925845↗
  9. CA125 is superior to CA19-9 in predicting the resectability of pancreatic cancer. Co-author DOI 10.1007/s11605-013-2389-9↗
  10. Highly lymphatic metastatic pancreatic cancer cells possess stem cell-like properties. Co-author DOI 10.3892/ijo.2013.1780↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jiang Long · 10 shared papers, 2013–2017 · strength 0.50
  2. Xianjun Yu · 10 shared papers, 2013–2017 · strength 0.50
  3. Chen Liu · 10 shared papers, 2013–2017 · strength 0.50
  4. Guopei Luo · 10 shared papers, 2013–2017 · strength 0.50
  5. Quanxing Ni · 9 shared papers, 2013–2017 · strength 0.47
  6. Jin Xu · 8 shared papers, 2013–2017 · strength 0.39
  7. Meng Guo · 7 shared papers, 2015–2017 · strength 0.39
  8. Kaizhou Jin · 7 shared papers, 2015–2017 · strength 0.39
  9. Liang Liu · 7 shared papers, 2013–2017 · strength 0.34
  10. Zhiwen Xiao · 7 shared papers, 2013–2017 · strength 0.33
  11. He Cheng · 4 shared papers, 2016–2017 · strength 0.23
  12. Liang Liu · 1 shared paper, 2017 · strength 0.07
  13. Yu‐Tang Gao · 1 shared paper, 2017 · strength 0.06
  14. Chuntao Wu · 1 shared paper, 2014 · strength 0.04
  15. Min Li · 1 shared paper, 2013 · strength 0.03
  16. Xiaobo Cui · 1 shared paper, 2013 · strength 0.03
  17. Si Shi · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.